CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 68 enrolled
Drug / intervention
Stimulant medication therapy +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00632619
NCT00632619N/ACompleted

A Novel Multimodal Intervention for Children With ADHD and Impaired Mood

Florida International University·interventional·Posted Mar 11, 2008·Updated May 21, 2013

In Brief

A clinical study evaluating Group-based behavior therapy, Stimulant medication therapy, and 1 other intervention for Attention Deficit Disorder With Hyperactivity. Completed, enrolled 68 participants across 1 site.

Detailed Summary

This study will evaluate the effectiveness of an integrative group psychosocial therapy combined with stimulant medication in treating children with attention deficit hyperactivity disorder plus impairments in mood.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 11, 2008
Enrollment StartMar 1, 2009
Primary CompletionJun 1, 2011
Study CompletionSep 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 18.3 years ago

Interventions

Group-based behavior therapybehavioral

Group-based behavior therapy with a parenting class will include 12 weeks of sessions that focus on reducing oppositional and aggressive behaviors. Children will participate in 12 weeks of social skills training integrated with a cognitive behavioral therapy (CBT) component to target mood symptoms. Parents will learn ways to identify and address their child's mood problems, communicate better with their child, and work with school staff to address academic and behavioral problems.

Stimulant medication therapydrug

All participants will be stabilized on an FDA-approved stimulant medication for 2 to 6 weeks prior to therapy assignment.

Community-based psychosocial treatmentbehavioral

Participants will receive referrals to community-based psychosocial treatments that will focus on ADHD symptoms and management of aggression.